Characterization of Potential Melanoma Predisposition Genes in High-Risk Brazilian Patients
Authors:
- Bianca Costa Soares de SáBSBianca Costa Soares de Sá
- Luciana Facure MoredoLMLuciana Facure Moredo
- Giovana Tardin TorrezanGTGiovana Tardin Torrezan
- Felipe FidalgoFFFelipe Fidalgo
- Érica Sara Souza de AraújoÉAÉrica Sara Souza de Araújo
- Maria Nirvana FormigaMFMaria Nirvana Formiga
- João Pereira DupratJDJoão Pereira Duprat
- Dirce Maria CarraroDCDirce Maria Carraro
Open Access
- 31 October 2023
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (21) , 15830
Abstract
Increased genetic risk for melanoma can occur in the context of germline pathogenic variants in high-penetrance genes, such as CDKN2A and CDK4, risk variants in low- to moderate-penetrance genes (MC1R and MITF), and possibly due to variants in emerging genes, such as ACD, TERF2IP, and TERT. We aimed to identify germline variants in high- and low- to moderate-penetrance melanoma risk genes in Brazilian patients with clinical criteria for familial melanoma syndrome. We selected patients with three or more melanomas or melanoma patients from families with three tumors (melanoma and pancreatic cancer) in first- or second-degree relatives. Genetic testing was performed with a nine-gene panel (ACD, BAP1, CDK4, CDKN2A, POT1, TERT, TERF2IP, MC1R, and MITF). In 36 patients, we identified 2 (5.6%) with germline pathogenic variants in CDKN2A and BAP1 and 4 (11.1%) with variants of uncertain significance in the high-penetrance genes. MC1R variants were found in 86.5%, and both red hair color variants and unknown risk variants were enriched in patients compared to a control group. The low frequency of germline pathogenic variants in the high-penetrance genes and the high prevalence of MC1R variants found in our cohort show the importance of the MC1R genotype in determining the risk of melanoma in the Brazilian melanoma-prone families.Keywords
Funding Information
- Fundo de Apoio à Dermatologia do Estado de São Paulo—Sebastião Sampaio (28/2015, 2014/50943-1, 465682/2014-6, 88887.136405/2017-00)
- Fundação de Amparo à Pesquisa do Estado de São Paulo (28/2015, 2014/50943-1, 465682/2014-6, 88887.136405/2017-00)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (28/2015, 2014/50943-1, 465682/2014-6, 88887.136405/2017-00)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (28/2015, 2014/50943-1, 465682/2014-6, 88887.136405/2017-00)
This publication has 46 references indexed in Scilit:
- Melanocortin 1 receptor and risk of cutaneous melanoma: A meta‐analysis and estimates of population burdenInternational Journal of Cancer, 2011
- Association of MC1R Variants and Host Phenotypes With Melanoma Risk in CDKN2A Mutation Carriers: A GenoMEL StudyJNCI: Journal of the National Cancer Institute, 2010
- Defining the patient at high risk for melanomaInternational Journal of Dermatology, 2010
- Selection criteria for genetic assessment of patients with familial melanomaJournal of the American Academy of Dermatology, 2009
- Melanoma Epidemiology and Public HealthDermatologic Clinics, 2009
- Familial MelanomaSurgical Clinics of North America, 2008
- Clinical and Molecular Characterization of Patients at Risk for Hereditary Melanoma in Southern BrazilJournal of Investigative Dermatology, 2008
- Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continentsJournal of Medical Genetics, 2006
- Cutaneous melanoma susceptibility and progression genesCancer Letters, 2005
- Sporadic multiple primary melanoma cases: CDKN2A germline mutations with a founder effectGenes, Chromosomes and Cancer, 2001